TGFB1 and hepatocellular carcinoma: In another model, Wu et al. subjected an HPC-like cell line (WB-F344) to long-term in vitro treatment with TGF-β, resulting in an AKT-dependent enhanced tumorigenic potential in NOD-SCID mice [129], and suggesting HPCs to be the source of TICs in HCC.